Positive impactResults
Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check status
Economic Times 1 hr ago·13 Aug 2026, 3:37 am
Molbio Diagnostics is set to announce the allotment status of its Rs 939.70 crore initial public offering (IPO) today. The issue was subscribed over 70 times, indicating strong investor demand. The company plans to use the raised funds to expand its research and development infrastructure and manufacturing capabilities. The IPO is scheduled to list on the stock exchanges on August 17.
The grey market premium (GMP) of around 20% suggests that the stock may open at a premium to its issue price. This positive sentiment reflects the high subscription levels and the company's growth prospects. Investors should check the allotment status on the official website of the registrar and the stock exchanges to know if they have been allotted shares.
Key takeaways
- Category: Results.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
